Overview
Total raised
$4.3M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 16, 2023 | Photonamic and Lumeda Enter into Collaboration for a Clinical Study with Photodynamic Therapy (“PDT”) in the Field of Non-Small Cell Lung Cancer (NSCLC) | ROCKY HILL, Conn. and PINNEBERG, Germany (PRWEB) February 16, 2023 Lumeda Inc, a clinical-stage medical technology company focused on improving treatment outcomes of patients with lung cancer, and photonamic GmbH & Co KG, a pharmaceutic... |
| Oct 28, 2021 | Lumeda Management Team Included in Hartford Business Journal’s Second Annual Power 25 Health Care List | ROCKY HILL, Conn. (PRWEB) October 28, 2021 Lumeda Inc., a medical technology company advancing photodynamic therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, today announced that its management t... |
| Jul 20, 2021 | Lumeda Announces Appointment of Jason Pesterfield to Board of Directors | ROCKY HILL, Conn. (PRWEB) July 20, 2021 Lumeda Inc., a medical technology company advancing Photodynamic Therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, today announced the appointment of Jason... |
| Apr 23, 2021 | Lumeda Selected as one of the 25 Technology Companies to Watch in the Greater Hartford Area | ROCKY HILL, Conn. (PRWEB) April 23, 2021 Lumeda Inc., a medical technology company focused on applying Photodynamic Therapy (PDT) as an adjuvant treatment for lung cancer patients, today announced it has been selected for inclusion in the H... |
| Apr 8, 2021 | Lumeda Announces Closing of $4.3M Series A Financing with Clinical Studies Due to Commence in 2021 | ROCKY HILL, Conn. (PRWEB) April 08, 2021 Lumeda Inc., a medical technology company advancing Photodynamic Therapy (PDT) as an intraoperative adjuvant treatment for patients during lung cancer surgery, today announced the closing of its Seri... |
| Apr 8, 2021 | Lumeda Announces $4.3M in Series A | ROCKY HILL, CT, Lumeda has announced the closing of a $4.3M Series A financing. >> Click here for more funding data on Lumeda >> To export Lumeda funding data to PDF and Excel, click here Lumeda, a medical technology comp... |
Reviews 0
FAQ about Lumeda
How much funding has Lumeda raised?
Lumeda has raised $4.3M in total across 1 funding round.
What has the press written about Lumeda?
Parsers VC has collected 7 articles mentioning Lumeda, among them “Photonamic and Lumeda Enter into Collaboration for a Clinical Study with Photodynamic Therapy (“PDT”) in the Field of Non-Small Cell Lung Cancer (NSCLC)” (Feb 16, 2023) and “Lumeda Management Team Included in Hartford Business Journal’s Second Annual Power 25 Health Care List” (Oct 28, 2021).
Is Lumeda still active?
Yes, Lumeda is active; its latest activity on Parsers VC dates from Jan 27, 2025.